Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
Z
Zenith Healthcare Ltd
Score 68/100• Decent
Zenith Healthcare Ltd shows potential for growth but faces several challenges that could impact its performance.
Company’s Health42/100
Valuation 60/100 · PB 2.5562
Technical Avoid
1M -8.223% 6M -20.674% 1Y -37.961%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#31
View details ➜
W
Windlas Biotech Ltd
Score 68/100• Decent
Windlas Biotech Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
Company’s Health84/100
Valuation 40/100 · PB 3.2589
Technical Avoid
1M -6.404% 6M -15.973% 1Y -26.115%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#32
View details ➜
V
Vilin Bio Med Ltd
Score 68/100• Decent
Vilin Bio Med Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
Company’s Health52/100
Valuation 80/100 · PB 1.1796
Technical Avoid
1M -18.58% 6M -27.374% 1Y -2.743%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#33
View details ➜
V
Venmax Drugs and Pharmaceuticals Ltd
Score 68/100• Decent
Venmax Drugs and Pharmaceuticals Ltd shows potential but faces challenges in growth consistency and valuation metrics.
Company’s Health72/100
Valuation 40/100 · PB 4.598
Technical Avoid
1M -12.126% 6M 3.571% 1Y 217.084%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#34
View details ➜
T
Tejnaksh Healthcare Ltd
Score 68/100• Decent
Tejnaksh Healthcare Ltd shows potential in the healthcare sector, but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health74/100
Valuation 80/100 · PB 1.1443
Technical Avoid
1M -15.294% 6M -30.588% 1Y -37.001%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#35
View details ➜
S
Suraksha Diagnostic Ltd
Score 68/100• Decent
Suraksha Diagnostic Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health79/100
Valuation 20/100 · PB 6.996
Technical Avoid
1M -9.869% 6M -13.758% 1Y -31.214%
Confidence100%
Low leverage (D/E)No promoter pledge
#36
View details ➜
S
Strides Pharma Science Ltd
Score 68/100• Decent
Strides Pharma Science Ltd shows potential but faces challenges in growth consistency and market competition.
Company’s Health61/100
Valuation 40/100 · PB 3.1451
Technical Avoid
1M -4.587% 6M 3.331% 1Y 24.998%
Confidence100%
Healthy profit marginsDecent revenue growth
Promoter pledge present
#37
View details ➜
S
Shilpa Medicare Ltd
Score 68/100• Decent
Shilpa Medicare Ltd shows potential for growth, but faces challenges in profitability and execution risks.
Company’s Health46/100
Valuation 60/100 · PB 2.7401
Technical Avoid
1M -16.443% 6M -31.197% 1Y -19.182%
Confidence100%
Low leverage (D/E)Decent revenue growth
Weak ROEPromoter pledge present
#38
View details ➜
S
SeQuent Scientific Ltd
Score 68/100• Decent
SeQuent Scientific Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
Company’s Health54/100
Valuation 20/100 · PB 6.9053
Technical Avoid
1M -10.035% 6M 7.749% 1Y 13.685%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#39
View details ➜
S
Senores Pharmaceuticals Ltd
Score 68/100• Decent
Senores Pharmaceuticals Ltd shows decent potential for growth and profitability, but caution is advised due to valuation concerns and execution risks.
Company’s Health80/100
Valuation 40/100 · PB 4.4571
Technical Watch
1M -1.649% 6M 43.935% 1Y 41.118%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#40
View details ➜
S
Sattva Sukun Lifecare Ltd
Score 68/100• Decent
Sattva Sukun Lifecare Ltd shows potential but faces significant challenges in growth and profitability metrics.
Company’s Health77/100
Valuation 100/100 · PB 0.8966
Technical Avoid
1M — 6M -52.212% 1Y -52.212%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#41
View details ➜
S
Sakar Healthcare Ltd
Score 68/100• Decent
Sakar Healthcare Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics.
Company’s Health79/100
Valuation 40/100 · PB 3.2917
Technical Watch
1M 4.072% 6M 35.109% 1Y 32.814%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#42
View details ➜
R
RPG Life Sciences Ltd
Score 68/100• Decent
RPG Life Sciences Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health100/100
Valuation 20/100 · PB 7.2213
Technical Avoid
1M -3.179% 6M 3.167% 1Y 1.634%
Confidence100%
Low leverage (D/E)No promoter pledge
#43
View details ➜
O
Onesource Specialty Pharma Ltd
Score 68/100• Decent
Onesource Specialty Pharma Ltd shows potential in a growing sector, but faces challenges in execution and profitability. Caution is advised due to valuation concerns and market risks.
Company’s Health41/100
Valuation 40/100 · PB 3.1864
Technical Avoid
1M -6.671% 6M -17.271% 1Y -4.368%
Confidence100%
Low leverage (D/E)Decent revenue growth
Weak ROEPromoter pledge present
#44
View details ➜
J
JHS Svendgaard Laboratories Ltd
Score 68/100• Decent
JHS Svendgaard Laboratories Ltd shows potential in a growing sector but faces challenges in consistency and valuation. Caution is advised.
Company’s Health42/100
Valuation 100/100 · PB 0.5026
Technical Avoid
1M -10.086% 6M -24.554% 1Y -55.759%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#45
View details ➜
Showing 31 to 45 of 301 (21 Pages)